# Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock

> **NCT07383103** · PHASE4 · RECRUITING · sponsor: **Northern Jiangsu People's Hospital** · enrollment: 336 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Hydrocortisone plus Fludrocortisone
- **OTHER:** Standard care

## Key facts

- **NCT ID:** NCT07383103
- **Lead sponsor:** Northern Jiangsu People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-02
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 336 (ESTIMATED)
- **Last updated:** 2026-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07383103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07383103, "Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT07383103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*